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APSS #3D: Pediatric adverse drug events

Executive summary checklist
Pediatric adverse drug events (pADEs) are harm and injury caused by medication in children.
During 2008 to 2012, the Institute for Safe Medication Practices (ISMP) reported there were
over 45,000 adverse drug events (ADEs) in children less than 18 years old and 64% of the ADEs
(29,298) involved a serious injury, including:
•
•
•
•

2,935 (6%) deaths
10,032 (22%) hospitalizations
1,430 (3%) life threatening cases
816 (2%) cases of disability (ISMP, 2014)

Create an action plan
 Create a multidisciplinary team specialized in neonatal and pediatric medication,
nursing, and pharmacy that reports regularly to executive leadership
 Use a software program to identify, detect, and report pADEs with analysis of the
incidence and characteristics of pADEs and the near-misses
 Set up a closed loop medication administration system with an electronic medication
administration record (eMAR) and barcoding, or other technology with computerized
provider order entry (CPOE)
 Collaborate in pADE reduction among all hospital systems during inpatient care and
transitions of care

Ensure best patient care
 Standardize order sets and protocols for each admitting diagnosis
 Use a CPOE with decision support systems (DSS) including medication reconciliation,
allergy checking, interaction checking, and dose range checking with alerts
 Use a double-check process of medication verification before dispensing
high-risk medications
 Ensure open communication and standardize medication handoffs between healthcare
teams at shift changes
 Use ‘smart’ drug infusion pumps with drug libraries that include pediatric standardized
medication amounts for all weight ranges

Engage staff and use data to find areas for improvement
 Use pediatric-specific technologiesto assure that basic resources to treat acutely ill or
injured children are present 24/7
 Ensure that the healthcare team reviews and understands the FDA Safety
Communication: “Syringe Pump Problems with Fluid Flow Continuity at Low Infusion
Rates Can Result in Serious Clinical Consequences”
 Use Continuous Quality Improvement (CQI) software from infusion pump manufacturers
to routinely monitor drug library parameters and report the frequency of command
overrides and alerts
 Use patient stories – in written and video form – to teach and inspire change in your staff
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What we know about pediatric adverse drug
events
Preventing ADEs in pediatric patients poses unique challenges because children are particularly
vulnerable to adverse outcomes from medication errors (preventable adverse events due to
wrong medication use). However, it can create a safety culture, which is a culture that promotes
patient safety and quality of care while reducing preventable risks and harm.
Children are especially vulnerable to pADEs due to these factors:
• The need for weight-based drug dosing involving multiple calculations
• Series dilution of stock medication solutions
• Immature renal and hepatic functions
• Limited ability to communicate side effects (Kaushal, 2001; Poole and Carleton, 2008)
• Some medications do not have an FDA-specific indication for children - more than 70%
of the medications used in pediatrics have not been studied in age-specific populations
to assess patient safety (Poole and Carleton,2008; Lindell-Osuagwu et al., 2009)

Problems with the standard treatment
Most medications used in the care of children are made and packaged primarily for adults.
There are limited dosage forms and amounts for newborns, infants, and children. Therefore,
healthcare professionals must often prepare medications in different volumes or amounts for
pediatric patients. Also, if an infusion pump is needed, they must provide an infusion rate that is
acceptable and within pump capabilities. When medications are not prepared in the pharmacy,
calculation errors and admixtures that do not account stability, compatibility, and bioavailability
data may pose additional challenges (Joint Commission, 2008).
Studies show that:
• Medication errors in pediatrics are up to 3 times more likely to have a potential pADE
compared to those in adults (Kaushal, 2001; Fortescue et al., 2003)
• Compared to other pediatric patient groups, the neonatal ICU patient group has the
highest error and potential pADE rate
• pADE rates in hospitalized children are as high as 19.1 per 1000 patient-days (Stockwell
et al., 2018)
• 22% of all pADEs could be prevented and 17.8% could have been identified earlier
(Takata et al., 2008)
• pADE rates were substantially higher in teaching hospitals, as well as in patients with
more chronic conditions (Stockwell et al., 2018).

Preventing pediatric adverse drug events (pADEs)
In 2001, the ISMP and the Pediatric Pharmacy Advocacy Group (PPAG) collaborated to produce
the nation’s first set of guidelines to reduce pediatric medication errors (ISMP, 2018). The
American Academy of Pediatrics (AAP) has also taken a lead in making recommendations to
reduce errors (AAP, 2003).
To reduce medication errors and preventable pADEs, all healthcare professionals, hospitals,
and healthcare systems need to create specific leadership, action, and technology plans. This
is especially important for community and rural hospitals, which usually treat a low numberof
pediatric patients. The limited experience, infrastructure deficiency, and highly variable
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training in pediatric prescribing and pharmacotherapy may place patients at increased risk of
medication errors (Benjamin et al., 2018; Marcin JP et al., 2007; Dharmar M et al., 2013).

The evidence for reducing pADEs
Research has found that use of an ADE trigger tool that is aligned with clinical protocols specific
for a medication can:
• Ensure more patient safety events compared to voluntary reporting (Burch, 2011; Call et
al., 2014)
• Identify ADEs and reduce the frequency for hospitalized pediatric populations (Takata et
al., 2008)
• Global Assessment of Pediatric Patient Safety (GAPPS) Trigger Tool developed by the
Center of Excellence for Pediatric Quality Measurement (CEPQM) consists of both the
manual approach and the automated approach (for automated screens of EHRs).
o The GAPPS Trigger Tool is shown to reliably identify pADEs and can be used for
monitoring quality improvement in healthcare facilities (Landrigan et al., 2016).
Studies in pediatrics have found a decrease in both prescribing errors and ADEs after using
technology, including:
• Electronic Health Records (EHR)
• Computerized provider order entry (CPOE) system (York et al., 2019)
• Barcode medication administration (BCMA)
• Bar code assisted medication preparation system (BCMP)
• Smart pump infusion technology (Manias, 2014)

Leadership plan
Hospital governance, senior administrative leadership, clinical leadership, and safety/risk
management leadership need to work collaboratively to reduce pADEs.
To achieve a goal of zero preventable deaths, leaders need to commit to taking these key
actions.

Show leadership’s commitment to pADEs
•

•
•

•

The hospital board, executives, and other senior administrative leadership (medicine,
pharmacy, and nursing) must fully understand the performance gaps (the difference
between the safety measurements and the ideal) in reducing pADEs at their own
healthcare systems
Leaders should endorse a comprehensive pADE reduction action plan and ensure it’s
applied across all providers and systems
Create a clear metric and goal to make pADE reduction a strategic priority - include
the metric and goal on the hospital-wide dashboard reviewed by the board and senior
executives
Invest and assign funds to:
o Create and maintain continuous education programs for healthcare providers about
pediatric clinical updates, high alert medications, pADEs monitoring, and proper use
of drug infusion pumps (Manias et al., 2014; Cimino et al., 2004; Keiffer et al., 2015;
Stump, 2000; Wolf, 2016).
o Support clinical and research programs to create “Best Practices” in pediatric medicine
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Engage staff
•
•

Promote communication among all disciplines involved in pediatric patient care,
including pharmacy staff, patients, and families (Fortescue, et al., 2003)
Use patient stories – in written and video form – to teach and inspire change in your staff

Make policy changes
•

•

•
•

Review pADE data at least monthly (Stump, 2000) – create a committee or task force
to review the reported data at the hospital and unit levels, create strategies for
improvement, analyze barriers, and report to executive leadership
Expect a root cause analysis of all pADEs that involve serious patient harm that includes:
o Root cause of the medication error
o Feedback to the individual linked to the error
o Time-bound and evidence-based changes to avoid similar pADEs
o Sharing of lessons learned (Stump, 2000)
Support lessons learned programs to raise awareness about pADE events, risks, and
improvement efforts among providers
Assess staff and ensure an adequate number of medical, nursing, and pharmacy staff
specially trained to prescribe, prepare, dispense, and give medications to children (ISMP,
2018; Catlin, 2004)

Create the infrastructure needed to make changes
•
•

•

Encourage and support the use of a simple, real-time pADE reporting system (Stump,
2000)
Consider opportunities for collaboration in pADE reduction both among and outside of
the pediatric hospital system, such as:
o The Exploring the Current Landscape of Intravenous Infusion Practices and Errors
(ECLIPSE)
o FDA-ASHP Standardize for Safety (S4S) Initiatives
o Ohio Children’s Hospitals’ Solutions for Patient Safety (OCHSPS) (Blandford et al., 2016)
Use and share technology that supports community practitioners as they treat and
transfer infants and children

Action plan
Ensure accountability
•
•
•

Create and maintain a pediatric formulary system with policies for medication
evaluation, selection, and use (Joint Commission, 2008; ISMP, 2018)
Create a smart infusion pump drug library with support for intravenous therapy for
pediatric patients (Manrique-Rodriguez et al., 2012)
Create a pediatric multidisciplinary team to:
o Achieve hospital-wide pADE reduction goals
o Monitor pADE metrics
o Ensure outstanding event reporting systems, root cause analyses, lessons learned
processes and improvement strategies for pADE reduction
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•

•

•
•

o Benchmark the adequacy of the features of the individual hospital’s medication
safety practices and clinical information systems against the proven best practices,
identify gaps, and make recommendations
Ensure adequate pharmacy services for pediatric patients to reduce medication errors
and ADEs (Manias et al., 2014) based on strategies proposed by the American College
of Clinical Pharmacy (ACCP) and the Pediatric Pharmacy Advocacy Group (PPAG)
(Bhatt-Mehta et al., 2013), and the guidelines for providing pediatric pharmacy services
in hospital and health systems developed by American Society of Health-System
Pharmacists (ASHP)-PPAG (Eiland et al., 2018):
o Elevate the minimum expectations for pharmacists entering pediatric practice
o Standard pediatric pharmacy education
o Expand the current number of pediatric clinical pharmacists
o Create an infrastructure for training of pediatric clinical pharmacists and
healthcare professionals.
o When possible, 24-hour pharmacy services should be available for the pediatric
population, especially in specialized, high-risk units (e.g., pediatric intensive care units,
neonatal ICU, hematology-oncology unit, operating rooms, and emergency department)
Create pharmacist-driven processes, such as:
o Admission medication histories and reconciliation process for pediatric patients
(Provine, Simmons, and Bhagat, et al., 2014)
o Discharge prescription review program, led by a clinical pharmacist (with pediatric
training preferred), to ensure the doses are the same with those prepared in the
hospital (Christiansen, Hilmas, Morgan, and Shepardson, et al., 2008)
o A double- and triple-check system for high alert medications to ensure the “5 Rights”,
appropriate medication selection, accurate excipients, dose, and concentrations of
liquid medication prior to compounding and dispensing them
o Managing drug product shortages including development of strategies for
identifying alternative therapies, working with suppliers, collaborating with physicians
and other healthcare providers as well as the Pharmacy and Therapeutics P&T
committee for specific clinical changes affecting pediatric patient care (Eiland et al.,
2018). For more information about mitigating drug shortages please refer to APSS
#3F: Drug Shortages.
Standardize equipment and measurement systems throughout the institution, such as
smart infusion pumps and weight scales for pediatric patients (Stucky, E.R., 2003)
Ensure best practices are used for syringe pumps with medications that require low
infusion rates (<5 mL per hour) (USFDA, 2016)

Create protocols
•

•

Prevent timing errors in medication administration by:
o Using a standard number of days in all pediatric protocols for treatment start date,
such as Day 0 or Day 1 (Joint Commission, 2008)
o Standardizing and limiting the number of concentrations and dosage strengths of
high alert medications to the minimum needed (Joint Commission, 2008; Irwin et al.,
2008; Hilmas, Sowan, Gaffoor, and Vaidya, 2009; Murray et al., 2014; Larsen et al., 2005)
Weigh and record all pediatric patients in kilograms only at the time of admission, or as
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•

•
•
•
•

•

soon as possible (i.e., within four hours of admission) in an emergency situation - weight
is used to calculate most dosing for children (Joint Commission, 2008)
List high alert medications for pediatric patients based on your types of pediatric
population, infrastructure, and unique features (Doherty and Donnell, 2012; Glanzmann,
Frey, Meier, and Vonbach, et al., 2015)
Create age-related treatment algorithms to guide providers to the correct dose for the
child’s age
Use reliable references and protocols to standardize pediatric medication therapies
Create CPOE order sets to help standardize care and medication therapy for specific
pediatric disease states with embedded dosing range maximums (Potts et al., 2003)
Embed a pediatric trigger toolkit in the CPOE as an alert system for prescribers when
medications are ordered out of range, or are duplicate therapies (Takata, 2008; Burch,
2011; Call, 2014) – it should electronically identify high risk medications based on the
therapeutic levels, doses, and pADEs
Create a smooth and effective communication process for hand-offs (e.g. using
a checklist) upon patient transfer to a different unit within the hospital, and upon
the transitions of care within and outside clinical settings (Robins and Dai, 2015;
Halsyamani et al., 2006; Manias et al., 2015; Manias et al., 2009; Apker, Mallack, and
Gibson, 2007

Provide training in pediatric medication safety
•

•
•

•

•
•

•

Create and integrate dedicated training in pediatric medication safety in the core
curricula of professional training programs in medical, nursing, and pharmacy schools
(Mueller et al., 2019; Benjamin et al., 2018; Szymusiak et al., 2018). For more on the
curriculum training, see APSS #17)
Create specialty training for all practitioners involved in the care of pediatric patients,
as well as continuous education programs for healthcare providers to stay current in
medications and treatment of pediatric conditions, and be familiar with the ongoing
pADE tracking and reporting systems (Joint Commission, 2008; ISMP, 2003)
Create a team of experts (e.g., physician, pharmacist, and nurse) to train healthcare
providers at their hospital on how to use the smart infusion pumps with customized
pediatric drug libraries (Manrique-Rodriguez et al., 2012b)
Have a dedicated pharmacist who is specifically trained or certified in pediatrics
pharmacy practice to oversee the pharmacotherapy of pediatric patients
Create an education forum for community healthcare providers (e.g., physicians,
pharmacists, and nurses) about appropriate prescribing and dispensing medications for
pediatric patients (Benavides, Huynh, Morgan, and Briars, 2011)
Have all staff and caregivers who use programmable syringe pumps review and
understand the FDA Safety Communication: “Syringe Pump Problems with Fluid Flow
Continuity at Low Infusion Rates Can Result in Serious Clinical Consequences” (FDA,
2016) - use Massachusetts General Hospital eLearning modules on this topic, that are
free at http://patient.sm/PGP6Zu

Track and analyze your progress
•
•

Take part in and track the progress of the FDA-ASHP Standardize for Safety Initiative
Evaluate clinical guidelines and protocols on a routine basis for sustainability and safety,
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•

•

especially when there is limited safety and efficacy data in the pediatric population
Use Continuous Quality Improvement (CQI) software from infusion pump manufacturers
to routinely track drug library parameters and to report the frequency of command
overrides and alerts triggered for unsafe practices (Ohashi, 2013; Bergon-Sendin, 2015)
Analyze and respond to identified issues from smart pump data

Report outcomes inside your organization and share best practices outside
your organization
•

•
•
•

Collaborate in a multidisciplinary team (e.g., physicians, pharmacists, and nurses) to
promote and endorse accountability and responsibility in reporting pADEs from all
healthcare providers (Crowther, Buck, McCarthy, and Barton, 2011; Stratton, Blegen,
Pepper, and Vaughn, 2004)
Work with the multidisciplinary healthcare team to create, improve, and optimize
reporting systems to identify, target, track, and monitor pADEs
Create real-time surveillance systems to identify high risk/high alert medications and
avoid pADEs
Share pediatric-specific assistive technologies such as eBroselow (or equivalent) to
assure that basic capabilities to stabilize and treat acutely ill or injured children are
present 24/7 throughout all environments of care (Damhoff, Kuhn, and Baker-Justice,
2014)

Technology plan
These suggested practices and technologies have shown proven benefit or, in some cases,
are the only known technologies for certain tasks. If you know of other options not listed here,
please complete the form for the PSMF Technology Vetting Workgroup to consider:
http://patient.sm/2sopQK
System or Practice

Available Technology

ONC Meaningful Use Certified EHR
system Electronic Health Record (EHR)
System with the following abilities:
•

Computerized Provider Order Entry
(CPOE)

•

Drug-drug interaction check

•

Drug-allergy interaction check

• Clinical Decision Support tools (CDS)
Standardized measuring tools for liquid
pediatric oral medication
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•

Oral syringes with better accuracy (Yin et al., 2016)

•

Provide measuring tools closely matched to
prescribed dose (Yin, et al., 2017)

Enhance the accessibility of tertiary
care for children, especially in rural and
underserved areas

•

•

Bar coded medication process for
pediatric medication products
(e.g., multi-dose or unit-dose vials,
compounded, and/or repackaged)
(ASHP, 2013.; Eiland et al., 2018)

Using telemedicine consultations in rural ED
to reduce physician-related ED medication
errors and to improve patient safety among
seriously ill and injured children (Dharmar et
al., 2013; Yang et al., 2015)
o Secure electronic communications,
information exchange, or other methods
that meet applicable state and federal
requirements.
Implementing a telepharmacy services to
provide round-the-clock medication order
review by pharmacists to reduce prescribing
errors (Wakefield, Ward, Loes, O’Brien, &
Sperry, 2010)

•

Use a bar code assisted medication
preparation system (BCMP) for intravenous
sterile compounding in pharmacy,

•

Use an electronic aid to help those who
compound parenteral medications on their
own to standardized concentrations for fluid
balance considerations for small patients
and patients with fluid restriction (Damhoff,
Kuhn, and Baker-Justice, et al., 2014)

•

Assure correct source vial identification,
container preparation, and Joint
Commission- compliant labeling of
drugs given by IV push or infusion in the
perioperative environment (Nanji, 2016).

Measuring outcomes
The most appropriate metric is the measure of adverse drug events. For more on this
measurement, see APSS #3A.

Conflicts of interest disclosure
The Patient Safety Movement Foundation partners with as many stakeholders as possible to
focus on how to address patient safety challenges. The recommendations in the APSS are
developed by workgroups that may include patient safety experts, healthcare technology
professionals, hospital leaders, patient advocates, and medical technology industry volunteers.
Some of the APSSs recommend technologies that are offered by companies involved in the
Patient Safety Movement Foundation. The workgroups have concluded, based on available
evidence, that these technologies work to address APSS patient safety issues. Workgroup
members are required to disclose any potential conflicts of interest.
APSS #3D | 139

Workgroup
Co-Chairs
Ron Jordan
Jerika Lam
Nathaniel Sims
Sun (Coco) Yang
Christopher Jerry

Chapman University School of Pharmacy
Chapman University School of Pharmacy
Massachusetts General Hospital
Chapman University School of Pharmacy
The Emily Jerry Foundation

Members
This list represents all contributors to this document since inception of the Actionable Patient
Safety Solutions.
Hania Alim

Patient Safety Movement Foundation

Peter Antevy

Handtevy

Steven Barker

Masimo; Patient Safety Movement Foundation

*Linda Beneze

Monarch Medical Technologies

Michel Bennett

Patient Safety Movement Foundation (formerly)

Laressa Bethishou

Chapman University School of Pharmacy

*Jim Broselow

eBroselow

John Burnam

Louise H. Batz Patient Safety Foundation

Mitchell Goldstein

Loma Linda Medical Center

Kari Hamlin

Hackensack Medical Center

Helen Haskell

Mothers Against Medical Error

Soojin Jun

Quorum Health

Edwin Loftin

Parrish Medical Center

Ariana Longley

Patient Safety Movement Foundation

Jacob Lopez

Patient Safety Movement Foundation (formerly)

Olivia Lounsbury

Patient Safety Movement Foundation

Anne Lyren

Children’s Hospitals’ Solutions for Patient Safety

Brendan Miney

Talis Clinical

Sidney Morice

Lee Health

Lisa Morrise

Consumers Advancing Patient Safety

Steve Mullenix

National Council for Prescription Drug Programs

*Flannery Nangle

Monarch Medical Technologies

Donna Prosser

Patient Safety Movement Foundation

Talia Puzantian

Keck Graduate Institute

Judith Reiss

Advocate

Claire Roy

Patient Safety Movement Foundation

Rochelle Sandell

Patient Advocate

140 | APSS #3D

Enrique Seoane-Vasquez Chapman University School of Pharmacy
Alex Shaffer

Advocate

David Shane Lowry

Rosalind Franklin University of Medicine and Science

Robin Shannon

The T System

Deeba Siddiqui

Hackensack Medical Center

Charles Simmons

Cedars-Sinai Medical Center

Nat Sims

Massachusetts General Hospital

Robert Stein

Keck Graduate Institute

Laura Townsend

Louise H. Batz Patient Safety Foundation

Kimberly Won

Chapman University School of Pharmacy

Jason Yamaki

Chapman University School of Pharmacy

Metrics integrity
Robin Betts
Kaiser Permanente, Northern California Region
*This Workgroup member has reported a financial interest in an organization that provides a
medical product or technology recommended in the Technology Plan for this APSS.

References
American Society of Health-System Pharmacists. (2013). ASHP Crosswalk of Guidances and
Standards for Managing Single (SDV) and Multi-Dose Vials (MDV). Retrieved from: https://
www.ashp.org/-/media/A908FB8EC74C4E57868CBB5431CCD557.ashx
Apker, J., Mallak, L. A. and Gibson, S. C. (2007). Communicating in the Gray Zone: Perceptions
about Emergency Physician-hospitalist Handoffs and Patient Safety. Academic Emergency
Medicine, 14(10), 884–894. doi:10.1197/j.aem.2007.06.037
Benavides, S., Huynh, D., Morgan, J. and Briars, L. (2011). Approach to the Pediatric Prescription
in a Community Pharmacy. J Pediatr Pharmacol Ther, 16, 298–307.
Bergon-Sendin,E., Perez-Grande, C. Lora-Pablos, D., Moral-Pumarega, M.T., Melgar-Bonis, A.,
Peña-Peloche, C.,...Pallas-Alonso, C.R. (2015). Smart pumps and random safety audits in a
Neonatal Intensive Care Unit: a new challenge for patient safety. BMC Pediatrics, 15, 206.
Bhatt-Mehta, V., Buck, M. L., Chung, A. M., Farrington, E. A., Hagemann, T. M., Hoff, D. S.,
… Parrish, R. H. (2013). Recommendations for Meeting the Pediatric Patients Need for a
Clinical Pharmacist: A Joint Opinion of the Pediatrics Practice and Research Network of
the American College of Clinical Pharmacy and the Pediatric Pharmacy Advocacy Group.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 33(2), 243–251.
doi:10.1002/phar.1246
Blandford, A., Furniss, D., Lyons, I., Chumbley, G., Iacovides, I., Wei, L., … Franklin, B. D. (2016).
Exploring the Current Landscape of Intravenous Infusion Practices and Errors (ECLIPSE):
Protocol for a Mixed-methods Observational Study. BMJ Open, 6(3), e009777. doi:10.1136/
bmjopen-2015-009777
Burch, K. J. (2011). Using a Trigger Tool to Assess Adverse Drug Events in a Children’s
Rehabilitation Hospital. J Pediatr Pharmacol Ther, 16, 204–9.
Call, R. J., Burlison, J. D., Robertson, J. J., Scott, J. R., Baker, D. K., Rossi, M. G., … Hoffman, J. M. (2014).
Adverse Drug Event Detection in Pediatric Oncology and Hematology Patients: Using
APSS #3D | 141

Medication Triggers to Identify Patient Harm in a Specialized Pediatric Patient Population. The
Journal of Pediatrics, 165(3), 447–452.e4. doi:10.1016/j.jpeds.2014.03.033
Catlin, A. (2004). Pediatric Medical Errors Part 2: Case Commentary. A Source of Tremendous
Loss. Pediatr Nurs, 30, 331–3, 335.
Christiansen, S. R., Morgan, J. A., Hilmas, E. and Shepardson, A. (2008). Impact of a Prescription
Review Program on the Accuracy and Safety of Discharge Prescriptions in a Pediatric Hospital
Setting. J Pediatr Pharmacol Ther, 13, 226–32.
Cimino, M. A., Kirschbaum, M. S., Brodsky, L. and Shaha, S. H. (2004). Assessing Medication
Prescribing Errors in Pediatric Intensive Care Units. Pediatric Critical Care Medicine, 5(2),
124–132. doi:10.1097/01.pcc.0000112371.26138.e8
Commission, J. (2008). Preventing Pediatric Medication Errors. Sentinel Event Alert, 39, 1–4.
Crowther, D. M., Buck, M. L., McCarthy, M. W. and Barton, V. W. (2011). Improving Pediatric
Adverse Drug Event Reporting through Clinical Pharmacy Services. J Pediatr Pharmacol Ther,
16, 285–90.
Damhoff, H. N., Kuhn, R. J. and Baker-Justice, S. N. (2014). Medication Preparation in Pediatric
Emergencies: Comparison of a Web-based, Standard-dose, Bar Code-enabled System and a
Traditional Approach. J Pediatr Pharmacol Ther, 19, 174–81.
Dharmar, M., Sadorra, C.K., Leigh, P., Yang, N.H., Nesbitt, T.S., Marcin, J.P. (2013). The financial
impact of a pediatric telemedicine program: a children’s hospital’s perspective. Telemedicine
Journal and E-Health, 19(7), 502-508.
Doherty, C. and Donnell, C. M. (2012). Tenfold Medication Errors: 5 Years Experience at
a University-Affiliated Pediatric Hospital. PEDIATRICS, 129(5), 916–924. doi:10.1542/
peds.2011-2526
Eiland, L.S., Benner, K, Gumpper, K., Heigham, M.K., Meyers, R., Pham, K. & Potts, A.L. (2018).
ASHP-PPAG guidelines for providing pediatric pharmacy services in hospitals and health
systems. American Journal of Health System Pharmacists, 75(15), 1151-1165.
Fortescue, E. B., Kaushal, R., Landrigan, C. P., McKenna, K. J., Clapp, M. D., Federico, F., … Bates,
D. W. (2003). Prioritizing Strategies for Preventing Medication Errors and Adverse Drug
Events in Pediatric Inpatients. PEDIATRICS, 111(4), 722–729. doi:10.1542/peds.111.4.722
Glanzmann, C., Frey, B., Meier, C. R. and Vonbach, P. (2015). Analysis of Medication Prescribing
Errors in Critically Ill Children. European Journal of Pediatrics, 174(10), 1347–1355.
doi:10.1007/s00431-015-2542-4
Halasyamani, L., Kripalani, S., Coleman, E., Schnipper, J., van Walraven, C., Nagamine, J., …
Manning, D. (2006).
Transition of Care for Hospitalized Elderly Patients: Development of a Discharge Checklist for
Hospitalists. Journal of Hospital Medicine, 1(6), 354–360. doi:10.1002/jhm.129
Hilmas, E., Sowan, A., Gaffoor, M. and Vaidya, V. (2009). Implementation and Evaluation
of a Comprehensive System to Deliver Pediatric Continuous Infusion Medications with
Standardized Concentrations. American Journal of Health-System Pharmacy, 67(1), 58–69.
doi:10.2146/ajhp080598
Irwin, D., Vaillancourt, R., Dalgleish, D., Thomas, M., Grenier, S., Wong, E., … Gaboury, I. (2008).
Standard Concentrations of High-alert Drug Infusions Across Pediatric Acute Care.. Paediatr
Child Health, 13, 371–6.
Institute for Safe Medication Practices.. (2014). QuarterWatch (Special Report): Adverse Drug
Events In Children Less than 18 Years Old. Retrieved from https://www.ismp.org/newsletters/
142 | APSS #3D

acutecare/showarticle.aspx?id=67
Institute for Safe Medication Practices. (2018). Targeted Medication Safety Best Practices for
Hospitals. Retrieved from: https://www.ismp.org/sites/default/files/attachments/2019-01/
TMSBP-for-Hospitalsv2.pdf
Kaushal, R. (2001). Medication Errors and Adverse Drug Events in Pediatric Inpatients. JAMA,
285(16), 2114. doi:10.1001/jama.285.16.2114
Keiffer, S., Marcum, G., Harrison, S., Teske, D. W. and Simsic, J. M. (2015). Reduction of
Medication Errors in a Pediatric Cardiothoracic Intensive Care Unit. Journal of Nursing Care
Quality, 30(3), 212–219. doi:10.1097/ncq.0000000000000098
Larsen, G. Y., Parker, H. B., Cash, J., O’Connell, M. and Grant, M. C. (2005). Standard Drug
Concentrations and Smart-pump Technology Reduce Continuous-medication-infusion Errors
in Pediatric Patients. Pediatrics, 116, e21–5.
Le, J., Nguyen, T., Law, A. V. and Hodding, J. (2006). Adverse Drug Reactions Among Children
Over a 10-Year Period. PEDIATRICS, 118(2), 555–562. doi:10.1542/peds.2005-2429
Lindell-Osuagwu, L., Korhonen, M. J., Saano, S., Helin-Tanninen, M., Naaranlahti, T. and Kokki,
H. (2009). Off-label and Unlicensed Drug Prescribing in Three Pediatric Wards in Finland and
Review of the International Literature. Journal of Clinical Pharmacy and Therapeutics, 34(3),
277–287. doi:10.1111/j.1365-2710.2008.01005.
Manias, E., Gerdtz, M. F., Weiland, T. J. and Collins, M. (2009). Medication Use Across Transition
Points from the Emergency Department: Identifying Factors Associated with Medication
Discrepancies. Annals of Pharmacotherapy, 43(11), 1755–1764. doi:10.1345/aph.1m206
Manias, E., Gerdtz, M., Williams, A. and Dooley, M. (2015). Complexities of Medicines Safety:
Communicating About Managing Medicines at Transition Points of Care Across Emergency
Departments and Medical Wards. J Clin Nurs, 24, 69–80.
Manias, E., Kinney, S., Cranswick, N., Williams, A. and Borrott, N. (2014). Interventions to Reduce
Medication Errors in Pediatric Intensive Care. Annals of Pharmacotherapy, 48(10), 1313–1331.
doi:10.1177/1060028014543795
Manrique-Rodríguez, S., Sánchez-Galindo, A., Fernández-Llamazares, C. M., López-Herce, J.,
Echarri-Martínez, L.,
Escudero-Vilaplana, V., … Ángel Carrillo-Álvarez. (2012). Smart Pump Alerts: All that Glitters
is Not Gold. International Journal of Medical Informatics, 81(5), 344–350. doi:10.1016/j.
ijmedinf.2011.10.010
Manrique-Rodríguez, S., Sánchez-Galindo, A., Fernández-Llamazares, C. M., López-Herce, J.,
García-López, I., Ángel Carrillo-Álvarez and Sanjuro-Sáez, M. (2012). Developing a Drug
Library for Smart Pumps in a Pediatric Intensive Care Unit. Artificial Intelligence in Medicine,
54(3), 155–161. doi:10.1016/j.artmed.2011.12.001
Murray, K. L., Wright, D., Laxton, B., Miller, K. M., Meyers, J. and Englebright, J. (2014).
Implementation of Standardized Pediatric i.v. Medication Concentrations. American Journal
of Health-System Pharmacy, 71(17), 1500–1508. doi:10.2146/ajhp140024
Nanji, K.C., Patel, A., Shaik, S., Seger, D.L., & Bates, D.W. (2016). Evaluation of perioperative
medication errors and adverse drug events. Anesthesiology, 124(1), 25-34.
Ohashi, K., Dykes, P., McIntosh, K., Buckley, E., Wien, M., & Bates, D.W. (2013). Evaluation of
intravenous medication errors with smart infusion pumps in an academic medical center.
AMA Annual Symposium Proceedings, 1089-98.
(2011). PEDIATRICS, 127(6), 1199–1210. doi:10.1542/peds.2011-0967
APSS #3D | 143

Practices, I. for S. M. (2014). QuarterWatch (Special Report): Adverse Drug Events In Children
Less than 18 Years Old. Retrieved from https://www.ismp.org/newsletters/acutecare/
showarticle.aspx?id=67
Provine, A. D., Simmons, E. M. and Bhagat, P. H. (2014). Establishment and Evaluation of
Pharmacist-Managed Admission Medication History and Reconciliation Process for
Pediatric Patients. The Journal of Pediatric Pharmacology and Therapeutics, 19(2), 98–102.
doi:10.5863/1551-6776-19.2.98
Poole, R. L. and Carleton, B. C. (2008). Medication Errors: Neonates, Infants and Children are the
Most Vulnerable! J Pediatr Pharmacol Ther, 13, 65–7.
Potts, A. L., Barr, F. E., Gregory, D. F., Wright, L. and Patel, N. R. (2003). Computerized Physician
Order Entry and Medication Errors in a Pediatric Critical Care Unit. PEDIATRICS, 113(1),
59–63. doi:10.1542/peds.113.1.59
Robins, H. M. and Dai, F. (2015). Handoffs in the Postoperative Anesthesia Care Unit: Use of a
Checklist for Transfer of Care. AANA J, 83, 264–8.
Stratton, K. M., Blegen, M. A., Pepper, G. and Vaughn, T. (2004). Reporting of Medication
Errors by Pediatric Nurses. Journal of Pediatric Nursing, 19(6), 385–392. doi:10.1016/j.
pedn.2004.11.007
Stucky, E. R., (2003). Prevention of medication errors in the pediatric inpatient setting. Pediatrics,
112(2), 431–436.
Stump, L. S. (2000). Re-engineering the Medication Error-reporting Process: Removing the
Blame and Improving the System. Am J Health Syst Pharm, 57 Suppl 4, S10–7.
Takata, G. S., Mason, W., Taketomo, C., Logsdon, T. and Sharek, P. J. (2008). Development Testing,
and Findings of a Pediatric-Focused Trigger Tool to Identify Medication-Related Harm in US
Childrens Hospitals. PEDIATRICS, 121(4), e927–e935. doi:10.1542/peds.2007-1779
United States Food & Drug Administration. (2016). Syringe Pump Problems with Fluid Flow
Continuity at Low Infusion Rates Can Result in Serious Clinical Consequences: FDA Safety
Communication. Retrieved from: https://www.fdanews.com/ext/resources/files/2016/08/0825-16-pumpsafetynotice.pdf?1480880246
Wakefield, D.S., Ward, M.M., Loes, J.L., O’Brien, J., & Sperry, L. (2010). Implementation of a
telepharmacy service to provide round-the-clock medication order review by pharmacists.
American Journal of Health-System Pharmacists, 67(23), 2052-2057.
Wolf, Z. R. (2016). Medication Errors Involving the Intravenous Administration Route. Journal of
Infusion Nursing, 39(4), 235–248. doi:10.1097/nan.0000000000000178
Yang, N.H., Dharmar, M., Kuppermann, N., Romano P.S., Nesbitt, T.S., Hojman, N.M., & Marcin,
J.P. (2015). Appropriateness of disposition following telemedicine consultations in rural
emergency departments. Pediatric Critical Care Medicine, 16(3), 59–64.
Yin, H.S., Parker, R.M., Sanders, L.M., Dreyer, B.P., Mendelsohn, A.L.. Bailey, S.,...Wolf, M.S. (2016).
Liquid medication errors and dosing tools: A randomized controlled experiment. Pediatrics,
138(4). doi:10.1542/peds.2016-0357
Yin, H.S., Parker, R.M., Sanders, L.M., Mendelsohn, A., Dreyer, B.P., Bailey, S.C.,...Wolf, M.S.
(2017). Pictograms, units and dosing tools, and parent medication errors: A randomized
study. Pediatrics, 140(10). doi: 10.1542/peds.2016-3237.

144 | APSS #3D

APSS #3D | 145

